(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 2.71% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.74%.
Quidelortho's revenue in 2025 is $2,714,400,000.On average, 10 Wall Street analysts forecast QDEL's revenue for 2025 to be $187,762,776,560, with the lowest QDEL revenue forecast at $180,018,581,000, and the highest QDEL revenue forecast at $194,148,341,320. On average, 10 Wall Street analysts forecast QDEL's revenue for 2026 to be $192,314,189,740, with the lowest QDEL revenue forecast at $183,347,226,460, and the highest QDEL revenue forecast at $201,281,153,020.
In 2027, QDEL is forecast to generate $200,465,974,540 in revenue, with the lowest revenue forecast at $189,596,928,140 and the highest revenue forecast at $210,519,842,460.